Cargando…
S152: COMBINATORY THERAPY OF ASCIMINIB AND PONATINIB WAS EFFECTIVE IN THE TREATMENT OF BLAST PHASE CML CDX MODEL
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428316/ http://dx.doi.org/10.1097/01.HS9.0000967520.71557.f0 |
| _version_ | 1785090438630211584 |
|---|---|
| author | Čuřík, Nikola Laznicka, Adam Polivkova, Vaclava Křížková, Jitka Semerak, Pavel Pokorna, Eva Suchankova, Pavla Burda, Pavel Hochhaus, Andreas Machová Poláková, Kateřina |
| author_facet | Čuřík, Nikola Laznicka, Adam Polivkova, Vaclava Křížková, Jitka Semerak, Pavel Pokorna, Eva Suchankova, Pavla Burda, Pavel Hochhaus, Andreas Machová Poláková, Kateřina |
| author_sort | Čuřík, Nikola |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428316 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104283162023-08-17 S152: COMBINATORY THERAPY OF ASCIMINIB AND PONATINIB WAS EFFECTIVE IN THE TREATMENT OF BLAST PHASE CML CDX MODEL Čuřík, Nikola Laznicka, Adam Polivkova, Vaclava Křížková, Jitka Semerak, Pavel Pokorna, Eva Suchankova, Pavla Burda, Pavel Hochhaus, Andreas Machová Poláková, Kateřina Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428316/ http://dx.doi.org/10.1097/01.HS9.0000967520.71557.f0 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Sessions Čuřík, Nikola Laznicka, Adam Polivkova, Vaclava Křížková, Jitka Semerak, Pavel Pokorna, Eva Suchankova, Pavla Burda, Pavel Hochhaus, Andreas Machová Poláková, Kateřina S152: COMBINATORY THERAPY OF ASCIMINIB AND PONATINIB WAS EFFECTIVE IN THE TREATMENT OF BLAST PHASE CML CDX MODEL |
| title | S152: COMBINATORY THERAPY OF ASCIMINIB AND PONATINIB WAS EFFECTIVE IN THE TREATMENT OF BLAST PHASE CML CDX MODEL |
| title_full | S152: COMBINATORY THERAPY OF ASCIMINIB AND PONATINIB WAS EFFECTIVE IN THE TREATMENT OF BLAST PHASE CML CDX MODEL |
| title_fullStr | S152: COMBINATORY THERAPY OF ASCIMINIB AND PONATINIB WAS EFFECTIVE IN THE TREATMENT OF BLAST PHASE CML CDX MODEL |
| title_full_unstemmed | S152: COMBINATORY THERAPY OF ASCIMINIB AND PONATINIB WAS EFFECTIVE IN THE TREATMENT OF BLAST PHASE CML CDX MODEL |
| title_short | S152: COMBINATORY THERAPY OF ASCIMINIB AND PONATINIB WAS EFFECTIVE IN THE TREATMENT OF BLAST PHASE CML CDX MODEL |
| title_sort | s152: combinatory therapy of asciminib and ponatinib was effective in the treatment of blast phase cml cdx model |
| topic | Oral Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428316/ http://dx.doi.org/10.1097/01.HS9.0000967520.71557.f0 |
| work_keys_str_mv | AT curiknikola s152combinatorytherapyofasciminibandponatinibwaseffectiveinthetreatmentofblastphasecmlcdxmodel AT laznickaadam s152combinatorytherapyofasciminibandponatinibwaseffectiveinthetreatmentofblastphasecmlcdxmodel AT polivkovavaclava s152combinatorytherapyofasciminibandponatinibwaseffectiveinthetreatmentofblastphasecmlcdxmodel AT krizkovajitka s152combinatorytherapyofasciminibandponatinibwaseffectiveinthetreatmentofblastphasecmlcdxmodel AT semerakpavel s152combinatorytherapyofasciminibandponatinibwaseffectiveinthetreatmentofblastphasecmlcdxmodel AT pokornaeva s152combinatorytherapyofasciminibandponatinibwaseffectiveinthetreatmentofblastphasecmlcdxmodel AT suchankovapavla s152combinatorytherapyofasciminibandponatinibwaseffectiveinthetreatmentofblastphasecmlcdxmodel AT burdapavel s152combinatorytherapyofasciminibandponatinibwaseffectiveinthetreatmentofblastphasecmlcdxmodel AT hochhausandreas s152combinatorytherapyofasciminibandponatinibwaseffectiveinthetreatmentofblastphasecmlcdxmodel AT machovapolakovakaterina s152combinatorytherapyofasciminibandponatinibwaseffectiveinthetreatmentofblastphasecmlcdxmodel |